Results 241 to 250 of about 33,140,363 (390)
Hybrid YOLOv3 and ReID intelligent identification statistical model for people flow in public places. [PDF]
Zheng Y.
europepmc +1 more source
Statistical Models of Orientational Phase Transition in Molecular Crystals [PDF]
Hiroshi Nakano
openalex +1 more source
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice +16 more
wiley +1 more source
BayesianSSA: a Bayesian statistical model based on structural sensitivity analysis for predicting responses to enzyme perturbations in metabolic networks. [PDF]
Hosoda S +6 more
europepmc +1 more source
Statistical Technique in Gas Dispersion Modeling Based on Linear Interpolation
Munirah Ramli, M. Shukri Z.A
openalex +2 more sources
Wenchao Zhang +4 more
semanticscholar +1 more source
Next‐generation proteomics improves lung cancer risk prediction
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj +4 more
wiley +1 more source
A statistical model of the motion of pastels under vibration (Poster)
Laurent Sauvage +4 more
openalex +1 more source
A Statistical Model for Higher Order DPA on Masked Devices
A. Ding, Liwei Zhang, Yunsi Fei, Pei Luo
semanticscholar +1 more source
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source

